Recombinant Vaccines Market Information: By Product (Subunit Recombinant and Attenuated Recombinant Vaccines), by Disease (Cancer, Pneumococcal Disease, Hepatitis B, and DPT), and End-Users (Pediatrics, Adults, and Veterinary) – Global Forecast Till 2027 Market Highlights The recombinant vaccines market is expected to exhibit a CAGR of 6.8% during the forecast period. Vaccines that are...